[go: up one dir, main page]

BG103684A - DERIVATIVES OF 2,3-DIHYDROFLUORO[3,2-b]PYRIDIN, METHOD FOR THEIR PREPARATION AND APPLICATION IN THERAPY - Google Patents

DERIVATIVES OF 2,3-DIHYDROFLUORO[3,2-b]PYRIDIN, METHOD FOR THEIR PREPARATION AND APPLICATION IN THERAPY

Info

Publication number
BG103684A
BG103684A BG103684A BG10368499A BG103684A BG 103684 A BG103684 A BG 103684A BG 103684 A BG103684 A BG 103684A BG 10368499 A BG10368499 A BG 10368499A BG 103684 A BG103684 A BG 103684A
Authority
BG
Bulgaria
Prior art keywords
alkyl group
dihydrofluoro
pyridin
therapy
derivatives
Prior art date
Application number
BG103684A
Other languages
Bulgarian (bg)
English (en)
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Thierry Gallet
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of BG103684A publication Critical patent/BG103684A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG103684A 1997-03-20 1999-08-24 DERIVATIVES OF 2,3-DIHYDROFLUORO[3,2-b]PYRIDIN, METHOD FOR THEIR PREPARATION AND APPLICATION IN THERAPY BG103684A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
BG103684A true BG103684A (en) 2000-06-30

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103684A BG103684A (en) 1997-03-20 1999-08-24 DERIVATIVES OF 2,3-DIHYDROFLUORO[3,2-b]PYRIDIN, METHOD FOR THEIR PREPARATION AND APPLICATION IN THERAPY

Country Status (22)

Country Link
US (1) US6143761A (xx)
EP (1) EP0971929A1 (xx)
JP (1) JP2001518099A (xx)
KR (1) KR20000076282A (xx)
CN (1) CN1251105A (xx)
AR (1) AR012097A1 (xx)
AU (1) AU6924298A (xx)
BG (1) BG103684A (xx)
BR (1) BR9808346A (xx)
CA (1) CA2282320A1 (xx)
CO (1) CO4940417A1 (xx)
EE (1) EE9900414A (xx)
FR (1) FR2761072B1 (xx)
HU (1) HUP0002335A3 (xx)
IL (1) IL131254A0 (xx)
NO (1) NO994527L (xx)
NZ (1) NZ337566A (xx)
PL (1) PL335759A1 (xx)
SK (1) SK127699A3 (xx)
TR (1) TR199902115T2 (xx)
WO (1) WO1998042713A1 (xx)
ZA (1) ZA982365B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
EP1977746B8 (en) 2007-04-02 2014-09-24 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT842178E (pt) * 1995-07-28 2001-08-30 Abbott Lab Furopiridina tienopiridina pirrolopiridina e compostos relacionados de pirimidina piridazina e triazina uteis no controlo da transmissao sinaptica quimica

Also Published As

Publication number Publication date
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
FR2761072B1 (fr) 1999-04-23
IL131254A0 (en) 2001-01-28
ZA982365B (en) 1998-09-23
CO4940417A1 (es) 2000-07-24
JP2001518099A (ja) 2001-10-09
NO994527D0 (no) 1999-09-17
HUP0002335A3 (en) 2002-07-29
CN1251105A (zh) 2000-04-19
NO994527L (no) 1999-11-18
EE9900414A (et) 2000-04-17
KR20000076282A (ko) 2000-12-26
WO1998042713A1 (fr) 1998-10-01
US6143761A (en) 2000-11-07
EP0971929A1 (fr) 2000-01-19
HUP0002335A2 (hu) 2001-05-28
AR012097A1 (es) 2000-09-27
AU6924298A (en) 1998-10-20
SK127699A3 (en) 2000-05-16
FR2761072A1 (fr) 1998-09-25
CA2282320A1 (en) 1998-10-01
BR9808346A (pt) 2000-05-23
NZ337566A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
GB9921150D0 (en) Therapeutic agents
BG104279A (en) Derivatives of 2,3-diarylpyrazolo[1,5-b]pyridazins, their preparation and application as cyclooxygenase-2 (cox-2) inhibitors
MY112232A (en) Indole derivatives
NZ512731A (en) Tricyclic inhibitors of poly(ADP-ribose) polymerases
MY118163A (en) Aryl fused azapolycyclic compounds
AU6607901A (en) Azaindole derivatives, process for their preparation, and their use as antitumoragents
BG101806A (en) Indole derivatives as 5-ht receptor antagoniss
NZ333706A (en) Benzenesulfone derivatives and medicaments
GB9927687D0 (en) Therapeutic agents
HUP9801340A1 (hu) Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények
BG102820A (en) Substituted tetracyclic tetrahydrofurane derivatives
NZ512981A (en) Use of pyridazino[4,5-b]indole-1-acetamide derivatives for treating diseases related to the dysfunction of peripheral benzodiazepine receptors
BG103684A (en) DERIVATIVES OF 2,3-DIHYDROFLUORO[3,2-b]PYRIDIN, METHOD FOR THEIR PREPARATION AND APPLICATION IN THERAPY
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
CA2252039A1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
BG103301A (en) Derivatives of 1h-pyrido(3,4-b)indol-4-carboxamide, method for their preparation and application as therapeutical means
DE69840388D1 (de) Camptothecin-analoge und verfahren zu ihrer herstellung
NZ330974A (en) Aminotetralin derivatives and pharmaceutical compositions thereof
IL122974A (en) Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
BG99566A (en) 4-quinoline derivatives with anti helicobacter activity
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
MXPA98005355A (es) Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.